Ignite Creation Date:
2024-05-06 @ 6:42 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05757245
Status:
RECRUITING
Last Update Posted:
2023-04-18
First Post:
2023-02-24
Brief Title:
A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia Participants
Sponsor:
First Affiliated Hospital of Guangxi Medical University
Organization:
First Affiliated Hospital of Guangxi Medical University
Organization Data
Organization:
First Affiliated Hospital of Guangxi Medical University
Class:
OTHER
Study ID:
GMCN-508A-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
First Affiliated Hospital of Guangxi Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Yongrong Lai
Responsible Party Title:
MD Director of Hematology Department of First Affiliated Hospital of Guangxi Medical University
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
First Affiliated Hospital of Guangxi Medical University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genmedicn Biopharma Ltd | UNKNOWN |